Are You a Faculty Member?
If you are a faculty member and would like to make a change to your faculty profile, please login to Profile+ with your UT Southwestern Id and password. Questions? Please email Web Services.
Ellen Vitetta, PhD
Endowed Title: Scheryle Simmons Patigian Distinguished Chair in Cancer Immunobiology
Cancer Biology
Immunology
Molecular Microbiology
Contact Information
UT Southwestern Medical Center
5323 Harry Hines Boulevard
Dallas, Texas 75390
Office Phone: 214-648-1229
Office Fax: 214-648-1252
Biography
NAME: Ellen S. Vitetta
POSITION TITLE: Director/Professor
EDUCATION/TRAINING:
Connecticut College, New London, CT, BA, 1964
NYU Graduate/Medical School, New York, NY, PhD, MD, 1968
PROFESSIONAL EXPERIENCE:
1976 - Present Professor, Departments of Microbiology and Immunology, UT Southwestern;
1984 - 1988 Chairperson, Immunology Graduate Program, UT Southwestern;
1988 - Present Director, Cancer Immunobiology Center, Scheryle Simmons Patigian Distinguished Chair in Cancer Immunology, Distinguished Teaching Chair, UT Southwestern
PROFESSIONAL SOCIETIES, CONFERENCES, COMMITTEES (1990-2005)
Councilor, International Society of Immunopharmacology, 1991-
Co-Editor in Chief, Therapeutic Immunology, 1992-1997
Scientific Advisory Board, Howard Hughes Medical Institute, 1992-1995
NCI Division of Cancer Treatment, Board of Scientific Counselors, 1993-1994
Vice President and President, American Association of Immunologists, 1993-1995
Association for Women in Science, 1994-
Board of Scientific Counselors, Office of AIDS Research, 1995-1996
National Research Council, 2001-.
AWARDS (1990-2007)
NIH Merit Award, 1987-1997
Faculty Teaching Award, 1989, 1991-1996, 1999-2004
FASEB Excellence in Science Award, 1991
The Gibson D. Lewis Award for Cancer Control (Research Achievement), Texas Cancer Council, 1991
Abbott Clinical Immunology Award, American Society for Microbiologists, 1992
Past State President’ Award of the Texas Federation of Business and Professional Women’s Clubs, 1993
National Academy of Sciences, 1994
President, American Association of Immunologists, 1994-1995
UCLA Distinguished Professorship, 1994
Kinyoun Lecture, NIAID, NIH, 1994
Rosenthal Award, American Association for Cancer Research, 1995
College Medal, Connecticut College, 1997
America Women in Medicine, Distinguished Scientist Award, 1998
Academy of Cancer Immunology, 2001
National Research Council Liaison/NAS, 2001
American Association of Immunologists, Distinguished Mentoring Award, 2002
American Association for Cancer Research Charlotte Friend Award and Lecture, 2002
American Academy of Arts & Sciences Member, 2003
Texas Academy of Sciences, Member, 2004
Alpha Omega Alpha Honor Medical Society, Member, 2004
Southwestern Academy of Teachers, 2006
Texas Women’s Hall of Fame Award, 2006
UT Academy of Health Science Education, 2006
The Texas Academy of Medicine, Engineering and Science, 2006
National Academy of Science Institute of Medicine, 2006
Lifetime Achievement Award, American Association of Immunologists, 2007
PUBLICATIONS (480 total)
Smallshaw, J.E., Firan, A., Fulmer, J.R., et al. A Novel Recombinant Vaccine which Protects Mice Against Ricin Intoxication. Vaccine, 20:3422-3427., 2002.
Smallshaw, J.E., Ghetie, V., Rizo, J., et al. Genetic engineering of an immunotoxin to eliminate its ability to induce pulmonary vascular leak in mice. Nat. Biotechnol. 21:387-391,2003.
Spiridon, CI, Gunn, S. and Vitetta, E.S. A comparison of the in vitro activities of IgG and F(ab)2 fragments of a mixture of three monoclonal anti-Her-2 antibodies. Clin Can Res 10:3542-3551, 2004.
Ghetie, M-A., Marches, R., Kufert, S., Vitetta, E.S. An anti-CD19 antibody inhibits the interaction between P-gp and CD19, causes P-gp to translocate out of lipid rafts and chemosensitizes a MDR lymphoma cell line. Blood 104:1, 178-183, 2004.
Smallshaw, J.E., Coleman, E., Spiridon, C., Vitetta, E.S. The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3. J. Immunol 27:6,419-424,2004.
Pop, L. M., Liu, X, Ghetie, V., and Vitetta, E.S. The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half life. International Immunopharmacology, 5/7-8, 1279-1290, 2005.
Smallshaw, J., Richardson, J.A., Pincus, S., et al. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against Ricin. Vaccine, 23:4775-4784, 2005.
Education
| Graduate School | New York Medical College (1968) |
| Graduate School | New York Medical College (1966) |
Research Interests
Publications
Vitetta, E.S., Smallshaw, J.E., Coleman, E., Jafri, H., Foster, C., Munford, R., and Schindler, J , PNAS , Spring 2006; (103:7):2268-2273
Smallshaw, J.E., Richardson, J.A., and Vitetta, E.S , Vaccine , 2007; (25):7459=7469
Liu, X., Pop, L., Smallshaw, J.E., Ghetie, V., Vitetta, E.S , Int Immunopharma , 2006; (6:5):791-799
Smallshaw, J., Richardson, J.A., Pincus, S., Schindler, J., and Vitetta, E.S. , Vaccine , 2005; (23:39):4775-4784
Ghetie, M-A., Marches, R., Kufert, S., Vitetta, E.S. , Blood , 2004; (104:1):178-183
Related Links
Honors/Awards
Lifetime Achievement Award (2007)
Award (2007)
Member (2006)
Rosenthal Award (1995)
Member (1994)